HLA-DRB1
|
Major histocompatibility complex, class II, DR β 1 |
6p21.32 |
HLA class II β chain paralogue, presenting peptides derived from extracellular proteins |
Sarcoidosis, multiple sclerosis, rheumatoid arthritis, autism/schizophrenia |
[17,18,19,20,21,23,25] |
[29,30] |
[31,32] |
HLA-DQB1
|
Major histocompatibility complex, class II, DQ β 1 |
6p21.32 |
HLA class II β chain paralogue, presenting peptides derived from extracellular proteins |
Celiac disease, multiple sclerosis, Creutzfeldt-Jakob disease, systemic lupus erythematosus, autism/schizophrenia |
[17,18,19,20,22,25] |
[30] |
[31] |
HLA-DPB1
|
Major histocompatibility complex, class II, DP β 1 |
6p21.32 |
HLA class II β chain paralogue, presenting peptides derived from extracellular proteins |
Chronic beryllium disease, Wegener granulomatosis, chronic hepatitis B infection |
[24,25] |
[30,33] |
None |
HLA-B
|
Major histocompatibility complex, class I, B |
6p21.33 |
HLA class I heavy chain paralogue, presenting peptides derived from the endoplasmic reticulum lumen |
Behcet disease, pulmonary arterial hypertension, toxic epidermal necrolysis, spondyloarthropathy, Stevens-Johnson syndrome, Takayasu arteritis |
None |
[29,30] |
None |
HLA-DQA1
|
Major histocompatibility complex, class II, DQ α 1 |
6p21.32 |
HLA class II α chain paralogue, presenting peptides derived from extracellular proteins |
Myasthenia gravis, celiac disease, idiopathic achalasia |
None |
[29,30] |
None |
HLA-A
|
Major histocompatibility complex, class I, A |
6p22.1 |
HLA class I heavy chain paralogue, presenting peptides derived from the endoplasmic reticulum lumen |
Cancers, birdshot chorioretinopathy, myelodysplastic syndrome, toxic epidermal necrolysis |
None |
[30] |
None |
HLA-DPA1
|
Major histocompatibility complex, class II, DP α 1 |
6p21.32 |
HLA class II α chain paralogue, presenting peptides derived from extracellular proteins |
Granulomatosis with polyangiitis |
None |
[30] |
None |